Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
50–75
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Informed consent to participate in study.
Have had a single negative prostate biopsy within 6 months prior to enrollment in study.
Have a PSA (prostate specific antigen) between 2.5 and 10 if 50-60 years of age; or a PSA between 3.0 and 10 if over age 60.
Ability and will to participate in study for 4 years.
You may not be if
More than one previous negative prostate biopsy.
History of prostate cancer.
Previous prostate surgery.
Inability to urinate requiring the need of a catheter during the previous 2 years.
Any condition (other than benign prostatic hypertrophy) which may result in urinary symptoms or changes in urine flow rate.
Cancer within previous 5 years (other than basal or squamous cell cancers of the skin).
Any unstable serious medical condition.
Use within the past 12 months of finasteride (Proscar or Propecia), dutasteride (Avodart), testosterone, or drugs that can block the action of male hormones.
Clareo Health | "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
